DW5524

· Daewon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DW5524, covering 2026-01-20 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers [Phase 1]